The current study investigated how temporarily induced paresthesia in the moving limb affects the performance of a goal-directed target aiming task. Three-dimensional displacement data of 14 neurotypical participants were recorded while they pointed to a target on a computer monitor in four conditions: (i) paresthesia-full-vision; (ii) paresthesia-without-target vision; (iii) no-paresthesia-full-vision; (iv) no paresthesia-without-target vision. The four conditions were blocked and counterbalanced such that participants performed the paresthesia and no-paresthesia conditions on two separate days. To assess how aiming performance changed in the presence of paresthesia, we compared early versus late performance (first and last 20% of trials). We found that endpoint accuracy and movement speed were reduced in the presence of paresthesia, but only without target vision. With repetition, participants adjusted their movement performance strategy, such that with induced paresthesia, they used a movement strategy that included more pre-planned movements that depended less on online control.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526316 | PMC |
http://dx.doi.org/10.3390/brainsci13091341 | DOI Listing |
JAAPA
January 2025
Anne Wildermuth is an assistant professor in the School of Medicine at the Uniformed Services University in Bethesda, Md., and practices in emergency medicine with MedStar Emergency Physicians in Clinton, Md. At the time this article was written, Meagan Lantz and Erin Sagers were students in the PA program at the George Washington University in Washington, D.C. Ms. Lantz now practices in cardiothoracic surgery at Stanford Health Care in Palo Alto, Calif. Ms. Sagers now practices in orthopedics at EmergeOrtho Coastal Region in Wilmington, N.C. The authors have disclosed no potential conflicts of interest, financial or otherwise. The views expressed in this article are those of the authors and not of the Department of Defense, Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., or other federal agencies.
Because proton pump inhibitors (PPIs) are so commonly used, their safety and potential adverse reactions often are not considered. This article describes a patient whose paresthesias and severe muscle cramps were attributed to panic attacks but actually were caused by hypocalcemia secondary to PPI-induced hypomagnesemia. This case serves as a reminder that PPIs should be used cautiously and appropriately with consideration for regular monitoring of electrolytes and vitamin B12.
View Article and Find Full Text PDFCureus
November 2024
Internal Medicine, Baptist Health South Florida, Miami, USA.
Transverse myelitis (TM) is an uncommon but extensively documented neurological disorder marked by acute spinal cord inflammation, resulting in a spectrum of impairments including motor, sensory, and autonomic disturbances. We outline a rare case of viral-induced TM linked to COVID-19 and Coxsackie B viral infections. A 25-year-old healthy female patient presented with acute bilateral upper and lower extremity weakness, paresthesia, and urinary retention.
View Article and Find Full Text PDFNeurochem Int
November 2024
Division of Plastic and Reconstructive Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan; Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan. Electronic address:
Diabetic peripheral neuropathy, characterized by symptoms such as paresthesia, neuropathic pain, and potential lower limb amputation, poses significant clinical management challenges. Recent studies suggest that chronic hyperglycemia-induced Schwann cells (SCs) apoptosis contributes to neurodegeneration and impaired nerve regeneration, but the detailed mechanisms are still unknown. Our study investigated a mixed-sex type 2 diabetes mellitus (T2DM) rat model using leptin knockout (KO) to simulate obesity and diabetes-related conditions.
View Article and Find Full Text PDFToxicol Rep
December 2024
Department of Pharmacology, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai, Maharashtra, India.
Oxaliplatin is a third-generation anticancer agent with better efficacy, lower toxicity, and a broad spectrum of antineoplastic activity. Its use is frequently associated with chronic oxaliplatin-induced neuropathy (OIN), a cumulative phenomenon manifesting as loss of sensation, paresthesia, dysesthesia, and irresolvable fluctuations in proprioception that greatly affect the patients' quality of life. The inevitable nature and high incidence of OIN, along with the absence of efficacious preventive agents, necessitate the development of effective and reliable protective options for limiting OIN while maintaining anticancer activity.
View Article and Find Full Text PDFCureus
October 2024
Department of Prosthodontics, Manav Rachna Dental College, Faridabad, IND.
Attaining the appropriate relation of the denture base with the tissues for optimum retention and support poses various challenges. Retention and support of a prosthesis depend on capturing mucosa and limiting structures in undistorted form. The impression in the geriatric population and patients with maxillary and mandibular defects poses a challenge for prosthodontists.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!